Amgen's corporate giving initiatives are very diverse: research grants and fellowships; medical education grants; donations of cash, product and equipment; community involvement through corporate sponsorships; and cash donations and volunteerism by Amgen staff members. In addition, the Amgen Foundation gives grants and matches staff donations to eligible non-profits.Amgen Foundation
The Amgen Foundation is an integral component of Amgen's commitment to dramatically improve people's lives. To date, the Foundation has contributed over $200 million to nonprofit organizations across the United States, Puerto Rico and Europe that support the Foundation's areas of focus. more >Independent Medical Education
Amgen funds independent medical education to further its mission of contributing to the advancement of medicine and healthcare. Only educational programs for healthcare professionals provided by accredited organizations will be considered for funding. All applications must be compliant with PhRMA Code, AMA, FDA, ACCME, OIG and all applicable laws. more >Healthcare Donations
Amgen makes donations to qualified charitable organizations for the following purposes:
Through this avenue, Amgen makes charitable donations and sponsorships focused on humanitarian, social, education and community programs to qualified organizations that are not members of the U.S. healthcare community. Donations and sponsorships include support for fundraising events. more >Assistance for Patients with No Insurance or
Amgen provides our medicines at no cost to uninsured patients in the United States with no or limited drug coverage who could otherwise not afford treatment through two foundations. These foundations have supported hundreds of thousands of patients over the years.
The Safety Net Foundation is a nonprofit foundation supported by Amgen that provides Amgen products at no cost to qualifying people with no or limited drug coverage. The Safety Net Foundation covers Aranesp® (darbepoetin alfa), EPOGEN® (epoetin alfa), Neulasta® (pegfilgrastim), NEUPOGEN® (Filgrastim), Nplate® (romiplostim), Prolia® (denosumab), Sensipar® (cinacalcet), Vectibix® (panitumumab), and XGEVA® (denosumab). more >
As part of Amgen's mission to serve patients, the company is proud to support organizations that educate health care professionals on diseases and treatments, including: